(1aS,1bS,2S,5aR,6S,6aS)-1a-(Hydroxymethyl)-6-methoxy-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-D-glucopyranoside(CAS: 1617-84-1)

The compound is subject to regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA requirements. GHS classification would involve evaluating its physical, health, and environmental hazards. REACH regulations require registration of substances above a certain tonnage threshold, and FDA/EPA would have specific requirements for safety testing and environmental release.

There are several alternatives in synthesis, such as isomers or analogs of the compound. Common alternative reagents include glucose derivatives, methyl ethers, and other sugar-based compounds. These can serve as viable substitutes depending on the specific application requirements.

The market trend shows increasing interest in bioactive compounds and their applications in pharmaceuticals and natural products research. Research trends focus on exploring the therapeutic potential of such compounds, including their antioxidant, anti-inflammatory, and antiviral activities.

Waste containing the compound should be collected in sealed containers and properly disposed of through professional waste disposal services. Incineration is a common method for disposal, and environmental protection precautions should be taken to ensure no harmful substances are released into the environment. Follow local regulations for hazardous waste disposal.